Protagonist Therapeutics Inc
NASDAQ:PTGX
Protagonist Therapeutics Inc
NASDAQ:PTGX
Price:
99.19
USD
-2.76%
Market Closed
Market Cap:
$6.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
Dios Fastigheter AB
STO:DIOS
|
SE |
|
Bunge Ltd
NYSE:BG
|
US |
|
S
|
SP Group A/S
CSE:SPG
|
DK |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
Surgery Partners Inc
NASDAQ:SGRY
|
US |
|
Norfolk Southern Corp
NYSE:NSC
|
US |
|
Willis Lease Finance Corp
NASDAQ:WLFC
|
US |
|
OrganiGram Holdings Inc
TSX:OGI
|
CA |
|
Brown-Forman Corp
NYSE:BF.B
|
US |
|
Huntington Bancshares Inc
NASDAQ:HBAN
|
US |
|
Carlisle Companies Inc
NYSE:CSL
|
US |
|
O
|
Ondo InsurTech PLC
LSE:ONDO
|
UK |
|
Netstreit Corp
NYSE:NTST
|
US |
|
Koppers Holdings Inc
NYSE:KOP
|
US |
|
N
|
Neodecortech SpA
MIL:NDT
|
IT |
|
SMCP SA
PAR:SMCP
|
FR |
|
S
|
SISB PCL
SET:SISB
|
TH |
|
Mitsubishi HC Capital Inc
TSE:8593
|
JP |
|
Woolworths Group Ltd
ASX:WOW
|
AU |
|
Applied Industrial Technologies Inc
NYSE:AIT
|
US |
|
VICI Properties Inc
NYSE:VICI
|
US |
|
Vianet Group PLC
LSE:VNET
|
UK |
|
Becton Dickinson and Co
NYSE:BDX
|
US |
Wall St Price Targets
PTGX Price Targets Summary
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Wall Street analysts forecast PTGX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PTGX is 119.93 USD with a low forecast of 101 USD and a high forecast of 143.85 USD.
Lowest Forecast
Price Target
101
USD
2% Upside
Average Forecast
Price Target
119.93
USD
21% Upside
Highest Forecast
Price Target
143.85
USD
45% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PTGX's stock price target?
Price Target
119.93
USD
119.93
USD
According to Wall Street analysts, the average 1-year price target for PTGX is 119.93 USD with a low forecast of 101 USD and a high forecast of 143.85 USD.
What is the Revenue forecast for Protagonist Therapeutics Inc?
Projected CAGR
54%
54%
The compound annual growth rate for Revenue over the next 8 years is 54%.
